Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs

Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs

A bipartisan group of senators is aiming to relieve high insulin costs for more Americans. A new bill introduced last week would cap the cost of the lifesaving drug at $35 per month for people with private insurance plans, and launch a pilot program to provide more affordable insulin to uninsured Am